Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis

Status: Recruiting
Location: See all (6) locations...
Study Type: Observational
SUMMARY

The proposed study is a multicentric prospective observational cohort study of patients with suspected NVE. The study population includes those with Possible IE according to the modified Duke criteria and investigated at one of the 6 participating sites which include 2 cardiac centers, the MHI and the IUCPQ, as well as 4 tertiary care centers, the Jewish General Hospital , the McGill University Health Centre and the CHUS.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• 18 years of age or older, capable to provide informed consent;

• Referred for a FDG-PET/CT study

• Classified as having Possible IE prior to FDG-PET/CT imaging;

• Patients must be able to tolerate the physical/logistical requirements of a PET/CT scan.

Locations
Other Locations
Canada
Centre Hospitalier de l'Universite de Montreal
NOT_YET_RECRUITING
Montreal
Jewish General Hospital
RECRUITING
Montreal
McGill University Health Center
NOT_YET_RECRUITING
Montreal
Montreal Heart Institute
RECRUITING
Montreal
University Institute of Cardiology and Respirology of Quebec
NOT_YET_RECRUITING
Québec
Centre Hospitalier de l'Universite de Sherbrooke
NOT_YET_RECRUITING
Sherbrooke
Time Frame
Start Date: 2021-08-31
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 97
Treatments
Patients with suspected native valve endocarditis
Related Therapeutic Areas
Sponsors
Leads: Montreal Heart Institute

This content was sourced from clinicaltrials.gov